• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性乳腺癌的预后因素:单变量和多变量分析,包括组织学分级和c-erbB-2原癌基因的扩增。

Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene.

作者信息

Tsuda H, Tsugane S, Fukutomi T, Nanasawa T, Yamamoto H, Hirohashi S

机构信息

Pathology Division, National Cancer Center Research Institute and Hospital, Tokyo.

出版信息

Jpn J Clin Oncol. 1992 Aug;22(4):244-9.

PMID:1359174
Abstract

Post-recurrence survival was examined in 62 breast cancer patients who had undergone curative radical mastectomies between 1974 and 1976 and suffered recurrences within 127 months of surgery. The prognostic value of 11 clinical, histological and genetic factors, including histologic grade of malignancy and amplification of oncogenes was analyzed using univariate and multivariate analyses. Not only the site of first recurrence, clinical stage and size of primary tumor at initial surgery, and disease-free period, but also histologic grade and amplification of the c-erbB-2 proto-oncogene were significant prognostic indicators of recurrent breast cancer. Multivariate analysis using Cox's regression model, histologic grade and amplification of c-erbB-2 in the primary tumor, as well as clinical stage at surgery and site of first recurrence, were shown to be major independent prognostic factors of recurrent breast cancer. Because post-recurrence prognosis was strongly influenced by the clinical, histological and genetic status of the primary breast cancer, appropriate evaluation of the primary tumor for the grade of aggressiveness of the cancer cells, as well as the extent of cancer spread, seem to be important.

摘要

对62例在1974年至1976年间接受根治性乳房切除术且在术后127个月内复发的乳腺癌患者进行了复发后生存情况的研究。使用单因素和多因素分析方法,分析了包括恶性组织学分级和癌基因扩增在内的11个临床、组织学和遗传学因素的预后价值。不仅首次复发部位、临床分期、初次手术时原发肿瘤大小和无病生存期,而且组织学分级和c-erbB-2原癌基因的扩增都是复发性乳腺癌的重要预后指标。使用Cox回归模型进行的多因素分析表明,原发肿瘤的组织学分级和c-erbB-2扩增,以及手术时的临床分期和首次复发部位,是复发性乳腺癌的主要独立预后因素。由于复发后的预后受到原发性乳腺癌临床、组织学和遗传学状态的强烈影响,因此对原发性肿瘤进行癌细胞侵袭性分级以及癌症扩散程度的适当评估似乎很重要。

相似文献

1
Prognostic factors for recurrent breast cancer: univariate and multivariate analyses including histologic grade and amplification of the c-erbB-2 proto-oncogene.复发性乳腺癌的预后因素:单变量和多变量分析,包括组织学分级和c-erbB-2原癌基因的扩增。
Jpn J Clin Oncol. 1992 Aug;22(4):244-9.
2
Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.c-erbB-2基因扩增与淋巴结阴性乳腺癌疾病复发风险之间的相关性。
Cancer Res. 1991 Jan 15;51(2):556-67.
3
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.
4
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.在原发性人类乳腺癌中,与c-myc和c-erbB-2/neu扩增相比,Int-2/FGF3扩增是复发更好的独立预测指标。
Mod Pathol. 1994 Dec;7(9):900-5.
5
Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
Cancer Res. 1989 Jun 1;49(11):3104-8.
6
c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.在原发性乳腺癌中,c-myc基因扩增是比HER2/neu基因扩增更好的预后因素。
Cancer Res. 1992 Mar 1;52(5):1107-13.
7
ERBB2 amplification in breast cancer with a high rate of proliferation.具有高增殖率的乳腺癌中的ERBB2扩增。
Oncogene. 1991 Jan;6(1):137-43.
8
[Preliminary studies on c-erbB-2 protooncogene in breast cancer].
Zhonghua Zhong Liu Za Zhi. 1992 May;14(3):171-4.
9
Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer.c-erbB-2和ras表达在淋巴结阳性和阴性乳腺癌中的预后及预测相关性
Anticancer Res. 1994 May-Jun;14(3B):1441-50.
10
c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.c-erbB-2癌基因与乳腺癌中p53表达、细胞增殖及预后的关系
Anticancer Res. 1993 Jul-Aug;13(4):1147-52.

引用本文的文献

1
p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.高组织学分级的导管内和浸润性乳腺癌中的p53突变与c-erbB-2扩增
Jpn J Cancer Res. 1993 Apr;84(4):394-401. doi: 10.1111/j.1349-7006.1993.tb00149.x.